Michael D. West
2018 - BioTime
In 2018, Michael D. West earned a total compensation of $1.4M as Former Co, Chief Executive Officer at BioTime, a 16% decrease compared to previous year.
Compensation breakdown
| Bonus | $48,750 |
|---|---|
| Salary | $489,303 |
| Stock Awards | $36,781 |
| Other | $790,279 |
| Total | $1,365,113 |
West received $790.3K in other compensation, accounting for 58% of the total pay in 2018.
West also received $48.8K in bonus, $489.3K in salary and $36.8K in stock awards.
Rankings
In 2018, Michael D. West's compensation ranked 7,623rd out of 14,244 executives tracked by ExecPay. In other words, West earned more than 46.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,623 out of 14,244 | 47th |
Division Manufacturing | 2,962 out of 5,759 | 49th |
Major group Chemicals And Allied Products | 1,110 out of 2,122 | 48th |
Industry group Drugs | 939 out of 1,811 | 48th |
Industry Biological Products, Except Diagnostic Substances | 174 out of 339 | 49th |
Source: SEC filing on June 14, 2019.
West's colleagues
We found four more compensation records of executives who worked with Michael D. West at BioTime in 2018.
News
AgeX Therapeutics CEO Michael West's 2020 pay falls 46% to $561K
November 24, 2021
AgeX Therapeutics CEO Michael West's 2019 pay falls 24% to $1M
November 24, 2020
AgeX Therapeutics CEO Michael West's 2018 pay rises 2% to $1.7M
November 29, 2019
BioTime CEO Brian Culley's 2018 pay jumps 75% to $2.8M
June 14, 2019